###begin article-title 0
###xml 125 133 <span type="species:ncbi:9606">patients</span>
Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
Despite well-studied tumor hypoxia in laboratory, little is known about the association with other pathophysiological events in the clinical view. We investigated the prognostic value of hypoxia-inducible factor-1 alpha (HIF-1alpha) in hepatocellular carcinoma (HCC), and its correlations with inflammation, angiogenesis and MYC oncogene.
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 30 38 <span type="species:ncbi:9606">patients</span>
In a random series of 110 HCC patients, the mRNA of HIF-1alpha, inflammation related factors (COX-2, MMP7 and MMP9), angiogenesis related factors (VEGF and PDGFRA) and MYC in tumor tissue were detected by real-time RT-PCR and HIF-1alpha protein was assessed by immunohistochemistry. The correlations between HIF-1alpha mRNA and the factors mentioned previously, the relationship between HIF-1alpha and clinicopathologic features, and the prognostic value were analyzed.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 121 123 121 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 135 137 135 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 193 195 193 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 207 209 207 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 583 585 583 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 597 599 597 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 631 633 631 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 645 647 645 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
The expression of both HIF-1alpha mRNA and protein in HCC were independent prognostic factors for overall survival (OS) (P = 0.012 and P = 0.021, respectively) and disease-free survival (DFS) (P = 0.004 and P = 0.007, respectively) as well. Besides, the high expression of HIF-1alpha mRNA and protein proposed an advanced BCLC stage and more incidence of vascular invasion. The mRNA of HIF-1alpha had significantly positive correlations to that of COX-2, PDGFRA, MMP7, MMP9, MYC, except VEGF. In addition to HIF-1alpha, COX-2 and PDGFRA were also independent prognosticators for OS (P = 0.004 and P = 0.010, respectively) and DFS (P = 0.010 and P = 0.038, respectively).
###end p 6
###begin title 7
Conclusion
###end title 7
###begin p 8
###xml 56 63 <span type="species:ncbi:9606">patient</span>
HIF-1alpha in HCC plays an important role in predicting patient outcome. It may influence HCC biological behaviors and affect the tumor inflammation, angiogenesis and act in concert with the oncogene MYC. Attaching importance to HIF-1alpha in HCC may improve the prognostic and therapeutic technique.
###end p 8
###begin title 9
Background
###end title 9
###begin p 10
###xml 0 15 0 15 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HEPATOCELLULAR </bold>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
HEPATOCELLULAR carcinoma (HCC) is the sixth most common cancer and the third most common cause of death from cancer worldwide, with increasing incidence in western countries [1]. Surgical resection provides an opportunity for cure, but the outcome remains dismal due to frequent tumor recurrence. Recently, better appreciations of the role that tumor microenvironment plays in tumor progression have bring a paradigm shift in developing strategies for cancer management. As a consequence, renewed emphasis has been placed on key features of the tumor microenvironment, in particular hypoxia, leading us to explore hypoxia related parameters for more accurate classification of this fetal disease.
###end p 10
###begin p 11
###xml 112 113 112 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 211 212 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 530 531 522 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
As is well-recognized, hypoxia is a common mechanism in HCC as the solid tumor owing to aberrant visualization [2]. Accumulating data have shown that hypoxia can stimulate proliferation[3], induce angiogenesis [4], accelerate invasion [5] and is responsible for treatment resistance in HCC [6]. The adaptation of HCC cells to tissue hypoxia is of central importance for tumor progression, where inducing the ubiquitous transcription factor of hypoxia-inducible factor-1alpha (HIF-1alpha) expression appears to be a critical step [7].
###end p 11
###begin p 12
###xml 351 352 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
HIF-1alpha is a master regulator of essential adaptive responses to hypoxia, whose expression and transcriptional activity increasing exponentially with decreases in levels of cellular oxygen. In tumors, HIF-1alpha regulates proliferation, apoptosis, metastatic spread, and glucose metabolism by acting as a transcription factor for crucial proteins [8].
###end p 12
###begin p 13
###xml 185 186 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 187 189 183 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 386 393 <span type="species:ncbi:9606">patient</span>
Previous studies have been focusing on the clinical significance as well as experimental models of HIF-1alpha in many types of cancer, which have led to somewhat controversial results [9,10]. On the basis of its unquestioned role as a central regulator of tumor pathophysiology, elucidating HIF-1alpha's prognostic value in HCC is of great clinical importance, which may lead to better patient stratification and provide rational for hypoxia targeted therapies.
###end p 13
###begin p 14
###xml 113 115 113 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 294 296 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
Importantly, the presence of hypoxia is always associated with and accompanied by inflammation and angiogenesis [11,12]. Specifically, HIF-1alpha and the oncogene MYC, which is also a transcription factor, act in concert to "fine tune" cancer cells' adaptive responses to hypoxic environments [13].
###end p 14
###begin p 15
###xml 520 522 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 523 525 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 560 562 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 563 565 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 631 633 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 260 268 <span type="species:ncbi:9606">patients</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
In the present study, we measured mRNA expression of HIF-1alpha in tumor tissue from 110 randomly selected HCC patients. We found that HIF-1alpha expression was associated with aggressive phenotypes of HCC and could be an independent prognostic factor for HCC patients after curative hepatectomy. Meanwhile, we presented the real-time reverse-transcriptase polymerise-chain-reaction (RT-PCR) study in the same cohort of patients on a battery of core genes which play important roles in inflammation (COX-2, MMP7, MMP9) [14-16] and angiogenesis (VEGF, PDGFRA) [17,18], as well as MYC which was confirmed as a key hypoxia regulator [19], to find the correlation of HIF-1alpha with these factors that can also affect and reflect tumor behaviors. These factors were selected for at least two of the three aspects: being crucial in inflammation or angiogenesis; being active in tumor metastasis or invasion; being mechanistically related to hypoxia. At last, using in situ immunostaining of HIF-1alpha protein, we got a further confirmation of the clinical significance of this crucial factor.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
Patients and Specimens
###end title 17
###begin p 18
###xml 334 336 334 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 410 418 <span type="species:ncbi:9606">patients</span>
###xml 589 597 <span type="species:ncbi:9606">patients</span>
###xml 778 786 <span type="species:ncbi:9606">patients</span>
###xml 829 837 <span type="species:ncbi:9606">patients</span>
###xml 962 970 <span type="species:ncbi:9606">patients</span>
Under the following the inclusion and exclusion criteria: (a) distinctive pathologic diagnosis of HCC, (b) without anticancer treatment and distant metastases before surgery, (c) underwent primary and curative resection for HCC between 2002 and 2005, defined as macroscopically complete removal of the tumor, as described previously [20], and (d) with complete clinicopathologic and follow-up data, about 2000 patients underwent hepatectomy at Zhongshan Hospital, Fudan University between 2002 and 2005 were identified. Following approval by the Institutional Review Board, a total of 110 patients in this time, with available frozen tumor specimens from our prospectively established tissue bank, were chosen randomly to be entered in this retrospective study. The mean age of patients was 52.4 years (range: 28-75) and all the patients were classified with Barcelona Clinic Liver Cancer staging system (BCLC stage) [21]. Informed consent was obtained from all patients.
###end p 18
###begin p 19
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
###xml 398 406 <span type="species:ncbi:9606">patients</span>
A diagnosis of recurrence was confirmed by an elevated AFP level and typical imaging appearance in computed tomography and/or magnetic resonance imaging scan [20]. Overall survival (OS) was defined as the interval from surgery and death. Disease-free survival time (DFS) was defined as the interval from surgery to recurrence. The data was censored on last follow-up for living patients or for the patients in whom tumor recurrence was not diagnosed. The median follow-up time was 24.0 months (range: 1.5-68.0 mon; SE: 1.49).
###end p 19
###begin title 20
Real-time RT-PCR
###end title 20
###begin p 21
###xml 219 220 219 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
Total RNA was isolated from each specimen with Trizol reagent (Invitrogen, Carlsbad, CA) and then reverse transcribed with the oligo dT primers and SuperScript RT (Invitrogen). The PCR primers used were showed in Table 1. Quantitative real-time RT-PCR was performed by using a 384-well ABI 7900 HT (Applied Biosystems, Foster City, CA). In particular, for a single gene, PCR amplifications of all the 110 specimens were simultaneously performed on the same 384-well plate in duplicate to avoid potential variations. Duplicate RT-PCR samples in each assay were collapsed by averaging.
###end p 21
###begin p 22
Forward and reverse primers for the genes analyzed
###end p 22
###begin p 23
###xml 653 655 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 679 680 647 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S1">1</xref>
Cycling parameters were as follows: 2 min at 50degreesC and 10 min at 95degreesC followed by 40 cycles of 30 sec at 95degreesC and 2 min at 60degreesC. The relative changes in gene expression were calculated by the DeltaDeltaCt method using the SDS 2.1 software according to the manufacturer's instructions (Applied-Biosystems). The expression of each gene was related to its expression in the reference RNA pool from the 10 normal liver tissues used as a calibrator. To control for variability in cDNA quantity, integrity, and individual primer efficiency, data were normalized against two housekeeping genes (TBP and HPRT) as we previously described [22]. (See Additional file 1: Figure S1 for relative mRNA expression of HIF-1alpha, COX-2, MMP7, MMP9, VEGF, PDGFRA and MYC with the cut-off value determined by the X-tile software).
###end p 23
###begin title 24
Tissue microarray and Immunohistochemistry
###end title 24
###begin p 25
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
Tissue microarrays (TMA) were constructed as described previously [23]. Triplicates of 1-mm-diameter cylinders from representative areas of tumor center, away from necrotic, hemorrhagic and major fibrotic areas, were included in each case, along with different controls (spleen, lymph node, artery and glioma), to ensure reproducibility and homogenous staining of the slides. Serial sections (4 mum thick) were placed on slides coated with 3-aminopropyltriethoxysilane.
###end p 25
###begin p 26
###xml 121 127 <span type="species:ncbi:9986">Rabbit</span>
###xml 546 557 <span type="species:ncbi:3704">horseradish</span>
Immunohistochemical staining by the streptavidin-biotin-peroxidase complex method was performed as previously described. Rabbit polyclonal antibody to HIF-1alpha (ab65979; Abcam, Cambridge, UK) was used at a dilution of 1:50. Briefly, sections were dewaxed, hydrated, and washed. After neutralization of endogenous peroxidase and microwave antigen retrieval, slides were preincubated with blocking serum and then incubated overnight with the primary Ab. Then, the sections were serially rinsed, incubated with second antibodies, and treated with horseradish peroxidase-conjugated streptavidin. Reaction products were visualized with 3, 3'-diaminobenzidine tetrahydrochloride and counterstained with hematoxylin. For the negative control, the primary antibodies were replaced with phosphate buffered saline.
###end p 26
###begin p 27
###xml 765 767 761 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 910 912 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 936 937 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S2">2</xref>
The manual evaluation of HIF-1alpha expression involved location and degree of reactivity. Location of expression included not only the cell type but also that of the subcellular localization (i.e., nucleus, cytoplasm). Degree of expression was determined by assessing semiquantitatively percentage of positive nuclear staining cells in random four fields of each core as well as evaluating for cytoplasmic staining intensity in the entire disk. The final result was classified as follows: I, no staining; II, nuclear staining in less than 10% of cells and/or with weak cytoplasmic staining; III, nuclear staining in 10%-50% of cells and/or with moderate cytoplasmic staining; IV, nuclear staining in more than 50% of cells and/or with strong cytoplasmic staining [24] In statistical analysis, the grades I and II were considered to be low expression of HIF-1alpha protein, with III and IV as high expression [25]. (See Additional file 2: Table S1 for degree of HIF-1alpha immunohistochemical staining)
###end p 27
###begin p 28
Two independent investigators blind to the clinicopathologic data assessed the immunohistochemistry. When independent scoring of a case differed, the case was rechecked, and the final score was determined by recounting HIF-1alpha positive nuclear staining cells using a multiheaded microscope with both reviewers simultaneously viewing the slides.
###end p 28
###begin title 29
Statistical analysis
###end title 29
###begin p 30
The statistical analysis was done with SPSS 15.0 program. To assess the relationship between experimental results and clinicopathologic characteristics, Fisher's exact test and Spearman's rho coefficients test were carried out as appropriate. To find out the correlations between HIF-1alpha and other evaluated factors, Pearson Correlation test was used.
###end p 30
###begin p 31
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 415 417 415 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient survival distribution was calculated using the Kaplan-Meier method and compared with the log-rank test. Cut-point value of experiment results was determined by the X-tile software [26]. Univariate and multivariate analyses were based on the Cox proportional hazards regression model. All variables that were found to be statistical significant in univariate analysis were included in multivariate analysis. P < 0.05 (two-sided) was judged statistically significant.
###end p 31
###begin title 32
Results
###end title 32
###begin title 33
Correlation of HIF-1alpha mRNA to clinicopathologic features
###end title 33
###begin p 34
###xml 464 466 448 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 482 483 466 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 400 408 <span type="species:ncbi:9606">patients</span>
According to the optimal cut-point value of HIF-1alpha determined by the X-tile software, the expression of HIF-1alpha mRNA was defined as high expression in 42 specimens (38.2%) and low expression in 68 specimens (61.8%). The HIF-1alpha mRNA expression level has no correlation to gender, tumor size, encapsulation, number, hepatitis history, liver cirrhosis and preoperative AFP level, while older patients seems to have tumor with higher HIF-1alpha expression (P = 0.049) (Table 2).
###end p 34
###begin p 35
Correlations of HIF-1alpha mRNA and protein with clinicopathological characters
###end p 35
###begin p 36
Detailed legends: Fisher's exact tests were used for all the analysis of correlations.
###end p 36
###begin p 37
###xml 259 261 255 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 485 487 473 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 503 504 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 118 126 <span type="species:ncbi:9606">patients</span>
###xml 425 433 <span type="species:ncbi:9606">patients</span>
The HIF-1alpha mRNA expression level showed significantly positive correlation with vascular invasion. In all the 110 patients, 59 cases without tumor vascular invasion have a high expression rate of 28.8%, as compared with the high expression rate of 49.0% (P = 0.033) in cases with vascular invasion. Also, the HIF-1alpha mRNA expression level was significantly correlated to BCLC stages. The HIF-1alpha mRNA expression in patients at stage A was lower than those at stages B and C (P = 0.041) (Table 2).
###end p 37
###begin title 38
Correlation of HIF-1alpha to COX-2, MMP7, MMP9, VEGF, PDGFRA and MYC
###end title 38
###begin p 39
###xml 143 145 139 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 154 156 150 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 172 174 168 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 183 185 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 201 203 197 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 212 214 208 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 232 234 228 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 243 245 239 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 263 265 259 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 274 276 270 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 387 389 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 398 400 390 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 550 551 538 539 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
Significant positive correlations were observed between HIF-1alpha mRNA and the putative markers of inflammation, angiogenesis and MYC: COX-2 (P < 0.001, r = 0.708), MMP7 (P < 0.001, r = 0.593), MMP9 (P < 0.001, r = 0.384), PDGFRA (P < 0.001, r = 0.493) and MYC (P < 0.001, r = 0.230). However, there were no significant correlation between mRNA expression level of HIF-1alpha and VEGF (P < 0.183, r = 0.128). Of all the six parameters, COX-2, MMP7 and PDGFRA were the top three factors with the largest correlation coefficients to HIF-1alpha (Table 3).
###end p 39
###begin p 40
Correlations between HIF-1alpha mRNA and other molecular markers as well as prognostic significance.
###end p 40
###begin p 41
###xml 22 24 22 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 95 97 95 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 376 378 376 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Detailed legends: The P values for correlation were determined by spearman's coefficience. The P values for OS and DFS were calculated using multivariate Cox proportional hazards analysis. All factors were presented in different multivariable analysis respectively and variables were adopted for their prognostic significance by univariate analysis. NS means not significant (P > 0.05).
###end p 41
###begin title 42
Prognosis
###end title 42
###begin p 43
The OS and DFS rates were 80.0% and 67.6% at 1 year, and 51.4% and 43.7% at 5 years respectively, for the whole study population.
###end p 43
###begin p 44
###xml 354 355 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
On univariate analysis, sex, hepatitis history, cirrhosis, ALT level showed no prognostic significance for OS and DFS. AFP, gamma-GT, tumor differentiation, size, vascular invasion and encapsulation were found to be significant predictors for OS. Age, AFP, gamma-GT, tumor size, number, vascular invasion and encapsulation were predictors for DFS (Table 4).
###end p 44
###begin p 45
Univariate analyses of factors associated with survival and recurrence
###end p 45
###begin p 46
###xml 22 24 22 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
Detailed legends: The P values were calculated using univariate Cox proportional hazards analysis. Cut-point values of the experiment results were determined by the X-tile software.
###end p 46
###begin p 47
###xml 138 139 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 148 150 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 155 157 151 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 304 306 296 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 427 429 419 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 466 468 458 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 176 184 <span type="species:ncbi:9606">patients</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
Univariate analysis revealed that the HIF-1alpha mRNA expression level was associated with both OS (P = 0.001) and DFS (P = 0.001) (Table 4; Figure 1A and 1B). The OS rate for patients with high and low expression of HIF-1alpha mRNA were 63.2% and 88.9% at 1 year (P = 0.001), 30.4% and 62.5% at 5 year (P = 0.001) respectively. Similarly, the DFS rate for patients with high and low expression were 53.9% and 74.3% at 1 year (P = 0.004), 20.4% and 54.8% at 5 year (P = 0.004) respectively.
###end p 47
###begin p 48
###xml 0 90 0 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kaplan-Meier analysis of overall and disease-free survival for HIF-1&#945; mRNA and protein</bold>
Kaplan-Meier analysis of overall and disease-free survival for HIF-1alpha mRNA and protein. Low expression of HIF-1alpha mRNA (A, B) or protein (C, D) was associated with both prolonged survival and reduced recurrence. The P values were determined by the log-rank test.
###end p 48
###begin p 49
###xml 115 117 111 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 176 178 172 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 255 257 251 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 344 345 340 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 367 368 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 370 371 366 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S4">4</xref>
###xml 373 374 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S5">5</xref>
###xml 376 377 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S6">6</xref>
###xml 379 380 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S7">7</xref>
###xml 385 386 381 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S8">8</xref>
Further, multivariate analysis confirmed that HIF-1alpha mRNA expression was independent prognostic factor for OS (P = 0.012, hazard ratio: 2.167, 95%CI: 1.185-3.965) and DFS (P = 0.004, hazard ratio: 2.359, 95%CI: 1.325-4.201). In addition, for DFS, the P value was the smallest and the hazard ratio was the largest among these factors (Table 5 and Additional files 3, 4, 5, 6, 7 and 8 ).
###end p 49
###begin p 50
Multivariate analyses of factors associated with survival and recurrence
###end p 50
###begin p 51
###xml 22 24 22 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 400 401 396 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S3">3</xref>
###xml 403 404 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S4">4</xref>
###xml 406 407 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S5">5</xref>
###xml 409 410 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S6">6</xref>
###xml 412 413 408 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S7">7</xref>
###xml 418 419 414 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S8">8</xref>
Detailed legends: The P values were calculated using multivariate Cox proportional hazards analysis. Variables were adopted for their prognostic significance by univariate analysis and no significant correlation between each other. COX-2 mRNA, PDGFRA mRNA, MMP7 mRNA, VEGF mRNA and HIF-1alpha protein were presented in different multivariable analysis respectively. (For details see Additional files 3, 4, 5, 6, 7 and 8)
###end p 51
###begin p 52
###xml 203 205 199 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 221 223 217 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 248 250 244 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 266 268 262 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 340 342 336 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 358 360 354 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 385 387 381 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 403 405 399 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 606 608 598 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 662 664 654 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 701 703 693 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 823 825 815 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 858 860 850 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 876 878 868 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 904 906 896 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 922 924 914 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1003 1004 995 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 1009 1010 1001 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
###xml 540 548 <span type="species:ncbi:9606">patients</span>
Also, as for mRNA expression, COX-2 and PDGFRA, being correlated with HIF-1alpha with larger coefficients among the six parameters, showed significance for both OS and DFS on univariate analysis (COX-2: P = 0.014 for OS, P = 0.027 for DFS; PDGFRA: P = 0.044 for OS, P = 0.041 for DFS) and then strengthened on multivariate analysis (COX-2: P = 0.004 for OS, P = 0.010 for DFS; PDGFRA: P = 0.010 for OS, P = 0.038 for DFS). MMP7, which also correlated with HIF-1alpha, showed significance for OS on both uni- and multi-variate analyses, and patients with high MMP7 had a propensity of increased recurrence (P = 0.060). However, VEGF was only significant for DFS (P = 0.022) but has no influence on OS (P = 0.299) in univariate analysis. On multivariate analysis, VEGF was not a significant prognostic factor for recurrence (P = 0.081) any more. Neither MMP9 (P = 0.313 for OS, P = 0.607 for DFS) nor MYC (P = 0.862 for OS, P = 0.361 for DFS) had any prognostic value for either OS or DFS in HCC. (Tables 4 and 5)
###end p 52
###begin title 53
Immunohistochemical confirmation
###end title 53
###begin p 54
###xml 411 412 399 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
In HCC, positive staining of HIF-1alpha protein was observed mainly in cancer cells, and occasionally in infiltrating lymphocytes as well. In contrast, the fibroblasts and endothelial cells in tumor tissue always showed negative staining. HIF-1alpha protein was commonly detected in cytoplasm, whereas in some cases HIF-1alpha protein was detected mostly in nucleus. Representative images were showed in Figure 2.
###end p 54
###begin p 55
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Representative images of immunohistochemical staining</bold>
Representative images of immunohistochemical staining. A: Negative expression of HIF-1alpha protein (x 200). B: Positive expression of HIF-1alpha protein (x 200). C: HIF-1alpha protein localized in the cytoplasm (x 400). D: HIF-1alpha protein localized in the nucleus (arrows) (x 400). E: Negative staining in fibroblasts and endothelial cells (arrows) (x 400). F: Positive staining in lymphocytes (arrows) (x 400).
###end p 55
###begin p 56
###xml 344 346 340 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 377 378 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="S9">9</xref>
###xml 92 100 <span type="species:ncbi:9606">patients</span>
###xml 136 144 <span type="species:ncbi:9606">patients</span>
According to the optimal cut-point determined by the X-tile software, there were 71 (64.5%) patients with low expression and 39 (35.5%) patients with high expression. Although the immunohistochemical results were not totally in parallel with the RT-PCR results, protein expression of HIF-1alpha were highly correlated with the mRNA expression (P = 0.001). (See Additional file 9: Table S2 for correlations between HIF-1alpha mRNA and protein)
###end p 56
###begin p 57
###xml 291 293 279 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 319 321 307 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 338 339 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 70 77 <span type="species:ncbi:9606">patient</span>
The tumor HIF-1alpha protein expression level has no association with patient age, tumor size, number, encapsulation, hepatitis history and preoperative AFP. Similar to HIF-1alpha mRNA, the tumor HIF-1alpha protein expression level was significantly associated with tumor vascular invasion (P = 0.027) and BCLC stages (P = 0.039). (Table 2)
###end p 57
###begin p 58
###xml 252 254 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 292 294 288 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 397 399 393 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 436 438 432 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 161 168 <span type="species:ncbi:9606">patient</span>
High expression of protein also means the poor outcome. Both OS and DFS were better in low expression group than that of high expression group. The OS rates for patient with high and low expression of HIF-1alpha protein were 69.2% and 85.9% at 1 year (P = 0.015), 39.8% and 58.0% at 5 years (P = 0.015) respectively. Also, the DFS rates for high and low expression were 50.8% and 76.5% at 1 year (P = 0.009), 30.3% and 51.2% at 5 year (P = 0.009) respectively.
###end p 58
###begin p 59
###xml 95 97 91 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 115 117 111 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 133 134 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
###xml 143 145 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C</xref>
###xml 150 152 146 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1D</xref>
###xml 214 216 210 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 232 234 228 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 258 259 254 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">5</xref>
On univariate analysis, tumor HIF-1alpha protein expression level was significant for both OS (P = 0.027) and DFS (P = 0.012) (Table 4; Figure 1C and 1D), which were further authenticated on multivariate analysis (P = 0.021 for OS; P = 0.007 for DFS) (Table 5). These may indicate that the prognostic value of HIF-1alpha was further validated on protein level.
###end p 59
###begin title 60
Discussion
###end title 60
###begin p 61
###xml 183 184 183 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 566 568 562 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1051 1053 1035 1037 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 1150 1152 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1335 1336 1311 1312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 1516 1518 1488 1490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 826 829 <span type="species:ncbi:10116">rat</span>
It has been established that human solid tumors develop a pathophysiologic microenvironment during growth, characterized by an irregular microvascular network and regions of hypoxia [7]. Of clinical importance, hypoxia-related genes and proteins are potentially alternative endogenous markers, as compared with the inability and the cost of exogenous hypoxia markers [2]. In this study, we demonstrated for the first time that HIF-1alpha, at both mRNA and protein levels, is an independent prognostic factor for both survival and recurrence in HCC with the smallest P value as well as the largest hazard ratio for recurrence. In addition, we found that high expression of HIF-1alpha was significantly associated with an advanced stage and aggressive phenotypes. Several in vitro experimental studies sustained our results. In rat HCC models, tumor progression after hypoxia and chemotherapy was related to up-regulation of HIF-1alpha and subsequent VEGF production, and transcriptional blockade of HIF-1alpha could enhance their therapeutic efficacy [27]. In cell lines, HCC cell proliferation was inhibited by HIF-1alpha antisense oligonuclecotide [28]. As a key player in tumor progression, HIF-1alpha overexpression is associated with an increased mortality and treatment failure in various cancers although conflicting data exist [7]. The current study emphasizes the clinical significance of HIF-1alpha, suggesting that related therapy in the future is promising in reducing recurrence and prolonging survival [29].
###end p 61
###begin p 62
###xml 236 238 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 484 486 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 487 489 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 662 664 650 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 780 782 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 783 785 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 879 880 867 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 881 883 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 1084 1086 1068 1070 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 1227 1229 1207 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 1326 1328 1306 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 1329 1331 1309 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 1622 1624 1590 1592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1708 1710 1676 1678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 1720 1722 1688 1690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 1736 1738 1704 1706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1971 1973 1931 1933 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 1982 1984 1942 1944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
The underlying mechanisms that HIF-1alpha affects metastatic spread and selecting cells with more aggressive phenotypes have not been fully defined, but recent studies have shown a role for increased invasive capacity and inflammation [11]. Consistently, we found the importance of HIF-1alpha in HCC is associated with or may contribute to other markers related to inflammation, angiogenesis and invasion. COX-2, MMP7 and MMP9 were well-recognized factors in inflammation conditions [14-16]. Among these molecules, COX-2, being involved in the chronic inflammation-related development of HCC, correlated with HIF-1alpha with the largest correlation coefficient (r = 0.708). Mechanistically, hypoxia potently triggers COX-2 transcription in many kinds of cells in primary culture [30,31]. Also, hypoxia influences the expression of MMPs although the mechanisms are controversial [5,32]. The mRNA expression of MMP7, which can degrade various ECM proteins and support the role in tumor invasion and spread in HCC, has significant correlation to HIF-1alpha mRNA expression in our study (r = 0.593). However, MMP9, without any prognostic signifcance, seems to have less significant correlation to HIF-1alpha mRNA than MMP7 in HCC (r = 0.383). VEGF and PDGFRA promote the tumor angiogenesis in inflammation and hypoxia conditions [18,33]. HIF-1alpha was often considered a master regulator of VEGF expression and angiogenesis in hypoxia. However, in our study, VEGF has no significant correlations with HIF-1alpha. As suggested, the regulation of VEGF expression may be come true by HIF-1alpha-independent pathways in hypoxia [34]. Otherwise, studies have revealed hypoxia can upregulate the expression of PDGFA [10], PDGFB [35] and PDGFRB [36], with little information on the correlation between HIF-1alpha and PDGFRA. Our study provide the preliminary data that HIF-1alpha positively correlated with and thus may upregulate PDGFRA, also a crucial angiogenic factor, in HCC (P < 0.001, r = 0.493).
###end p 62
###begin p 63
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 551 553 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
All of these factors were conceived to promote tumor progression. Some of these molecules, such as COX-2, PDGFRA and MMP7, were believed to be prognostic factors in HCC according to our research. COX-2 may regulate HCC growth by COX-2-derived PG signaling pathway [37]. PDGFRA may regulate tumor angiogenesis by PDGFRA-p70S6K pathway which is related to the function of fibroblast growth factor (FGF) and expression of VEGF and hepatocytes growth factor (HGF) [18]. MMPs increase HCC invasion and growth through the degradation of extracellar matrix [38].
###end p 63
###begin p 64
###xml 55 57 51 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 536 538 528 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
However, we propose that HIF-1alpha, with the smallest P value as well as the largest hazard ratio for DFS among these factors, may be the central factor to affect HCC outcome. Extensive researches have confirmed that HIF-1alpha controls many hundreds of target genes which play important roles in the cellular adaptation to hypoxia, and the proteins of these genes are involved in processes which can make cancer cells much more aggressive, such as angiogenesis, proliferation, apoptosis, energy metabolism and glucose transportation [29].
###end p 64
###begin p 65
###xml 169 171 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 233 235 225 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 293 295 285 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">r </italic>
###xml 517 519 509 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 399 404 <span type="species:ncbi:9606">human</span>
In addition, the oncogene MYC also plays a crucial role in hypoxic response, and cooperates with HIF-1alpha to alter cellular metabolism and promote cancer progression [19]. In our study, MYC was positive correlated with HIF-1alpha (P = 0.016). However, the correlation coefficient was small (r = 0.230), and MYC has no prognostic value in HCC. The findings that MYC expression was repressed in the human hepatoma cell lines under extremely low oxygen concentrations may partly responsible for this non-significance [39].
###end p 65
###begin p 66
In summary, HIF-1alpha was an independent prognosticator for both survival and recurrence in HCC. Although the correlations between HIF-1alpha and markers of inflammation, angiogenesis and the cooperative MYC oncogene are not very clear, we can hypothesize that HIF-1alpha was the crucial factor in HCC progression on the basis of our findings. The therapy targeting HIF-1alpha and associated molecules may profoundly reduce recurrence and prolong survival.
###end p 66
###begin title 67
Conclusion
###end title 67
###begin p 68
HIF-1alpha was an independent prognosticator for both survival and recurrence in HCC. Markers of inflammation, angiogenesis and the cooperative MYC oncogene, who have closer correlation with HIF-1alpha, seem to be better for prognostic stratification, suggesting that HIF-1alpha was one of the most crucial factors in HCC progression. Attaching importance to HIF-1alpha and related molecules may improve the prognostic stratification and therapeutic technique.
###end p 68
###begin title 69
Abbreviations
###end title 69
###begin p 70
###xml 151 154 <span type="species:ncbi:10407?0.9699783742526397">HBV</span>
###xml 156 173 <span type="species:ncbi:10407">hepatitis B virus</span>
AFP: alpha-fetoprotein; BCLC stage: Barcelona Clinic Liver Cancer stage; CI: confidence interval; COX-2: cyclooxygenase-2; DFS: disease-free survival; HBV: hepatitis B virus; HCC: hepatocellular carcinoma; HIF-1alpha: hypoxia-inducible factor 1, alpha subunit; HPRT: hypoxanthine-guanine phosphoribosyltransferase; MMP: matrix metalloproteinase; OS: overall survival; PDGFRA: platelet-derived growth factor receptor, alpha polypeptide; RT-PCR: polymerase chain reaction; TBP: TATA binding protein; VEGF: vascular endothelial growth factor.
###end p 70
###begin title 71
Competing interests
###end title 71
###begin p 72
The authors declare that they have no competing interests.
###end p 72
###begin title 73
Authors' contributions
###end title 73
###begin p 74
JF developed the study concept, aims and initiated the project. QG and CXD performed the experimental work described in the study and were both responsible for the drafting of the manuscript. SJQ supervised the process of the whole research. JZ and BHZ provided valuable scientific suggestions. MJJ, MYC and YFX have participated in its design and coordination. All authors have read and approved the final manuscript.
###end p 74
###begin title 75
Pre-publication history
###end title 75
###begin p 76
The pre-publication history for this paper can be accessed here:
###end p 76
###begin p 77

###end p 77
###begin title 78
Supplementary Material
###end title 78
###begin title 79
Additional file 1
###end title 79
###begin p 80
###xml 0 142 0 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1: Relative expression of HIF-1&#945;, COX-2, MMP7, MMP9, VEGF, PDGFRA and MYC with the cut-off value determined by the X-tile software</bold>
Figure S1: Relative expression of HIF-1alpha, COX-2, MMP7, MMP9, VEGF, PDGFRA and MYC with the cut-off value determined by the X-tile software. The blue dots show the relative value of mRNA expression. The red lines show the cut-off value.
###end p 80
###begin p 81
Click here for file
###end p 81
###begin title 82
Additional file 2
###end title 82
###begin p 83
###xml 0 74 0 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1: Degree of HIF-1&#945; immunohistochemistry in tissue array of HCC</bold>
Table S1: Degree of HIF-1alpha immunohistochemistry in tissue array of HCC. I, no staining; II, nuclear staining in less than 10% of cells and/or with weak cytoplasmic staining; III, nuclear staining in 10%-50% of cells and/or with moderate cytoplasmic staining; IV, nuclear staining in more than 50% of cells and/or with strong cytoplasmic staining.
###end p 83
###begin p 84
Click here for file
###end p 84
###begin title 85
Additional file 3
###end title 85
###begin p 86
Figure S2: Kaplan-Meier analysis of OS and DFS for COX-2, MMP7, MMP9, VEGF, PDGFRA and MYC mRNA
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Additional file 4
###end title 88
###begin p 89
Table S3: Multivariate analyses of variables associated with survival and recurrence including mRNA expression of COX-2 as co-variable
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Additional file 5
###end title 91
###begin p 92
Table S4: Multivariate analyses of variables associated with survival and recurrence including mRNA expression of PDGFRA as co-variable
###end p 92
###begin p 93
Click here for file
###end p 93
###begin title 94
Additional file 6
###end title 94
###begin p 95
Table S5: Multivariate analyses of variables associated with survival and recurrence including mRNA expression of MMP7 as co-variable
###end p 95
###begin p 96
Click here for file
###end p 96
###begin title 97
Additional file 7
###end title 97
###begin p 98
###xml 0 142 0 138 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S6: Multivariate analyses of variables associated with survival and recurrence including protein expression of HIF-1&#945; as co-variable</bold>
Table S6: Multivariate analyses of variables associated with survival and recurrence including protein expression of HIF-1alpha as co-variable. (P = 0.021 for OS, P = 0.007 for DFS).
###end p 98
###begin p 99
Click here for file
###end p 99
###begin title 100
Additional file 8
###end title 100
###begin p 101
###xml 0 133 0 133 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S7: Multivariate analyses of variables associated with survival and recurrence including mRNA expression of VEGF as co-variable</bold>
Table S7: Multivariate analyses of variables associated with survival and recurrence including mRNA expression of VEGF as co-variable. (P = 0.081 for DFS).
###end p 101
###begin p 102
Click here for file
###end p 102
###begin title 103
Additional file 9
###end title 103
###begin p 104
Table S2: Correlations between HIF-1alpha mRNA and protein expression.
###end p 104
###begin p 105
Click here for file
###end p 105
###begin title 106
Acknowledgements
###end title 106
###begin p 107
This study was funded by Key Project of the Chinese Ministry of Education (no. 107039), National Key Sci-Tech Special Project of China (no. 2008ZX10002-018, 2008ZX10002-019), National Natural Science Foundation of China (no. 30700794) and the Doctoral Fund of Ministry of Education of China (no. 20060246075).
###end p 107
###begin article-title 108
Immunotherapy of HCC
###end article-title 108
###begin article-title 109
###xml 50 55 <span type="species:ncbi:9606">human</span>
Gene expression profiling of hypoxia signaling in human hepatocellular carcinoma cells
###end article-title 109
###begin article-title 110
###xml 36 41 <span type="species:ncbi:9606">human</span>
Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression
###end article-title 110
###begin article-title 111
###xml 32 37 <span type="species:ncbi:9606">human</span>
Hypoxia-induced angiogenesis in human hepatocellular carcinoma
###end article-title 111
###begin article-title 112
Hypoxia accelerates cancer invasion of hepatoma cells by upregulating MMP expression in an HIF-1alpha-independent manner
###end article-title 112
###begin article-title 113
Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma
###end article-title 113
###begin article-title 114
###xml 33 38 <span type="species:ncbi:9606">human</span>
The impact of O2 availability on human cancer
###end article-title 114
###begin article-title 115
Hypoxia-inducible factor 1, a master transcription factor of cellular hypoxic gene expression
###end article-title 115
###begin article-title 116
Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma
###end article-title 116
###begin article-title 117
###xml 63 71 <span type="species:ncbi:9606">patients</span>
High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF
###end article-title 117
###begin article-title 118
Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation
###end article-title 118
###begin article-title 119
Hypoxia and angiogenesis
###end article-title 119
###begin article-title 120
HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation
###end article-title 120
###begin article-title 121
COX-2 in inflammation and resolution
###end article-title 121
###begin article-title 122
###xml 167 178 <span type="species:ncbi:11103">hepatitis C</span>
Matrix metalloproteinase (MMP)-2, MMP-7, and tissue inhibitor of metalloproteinase-1 are closely related to the fibroproliferative process in the liver during chronic hepatitis C
###end article-title 122
###begin article-title 123
###xml 107 118 <span type="species:ncbi:11103">hepatitis C</span>
Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C
###end article-title 123
###begin article-title 124
Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications
###end article-title 124
###begin article-title 125
Essential role of PDGFRalpha-p70S6K signaling in mesenchymal cells during therapeutic and tumor angiogenesis in vivo: role of PDGFRalpha during angiogenesis
###end article-title 125
###begin article-title 126
The interplay between MYC and HIF in cancer
###end article-title 126
###begin article-title 127
Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection
###end article-title 127
###begin article-title 128
Prognosis of hepatocellular carcinoma: the BCLC staging classification
###end article-title 128
###begin article-title 129
###xml 50 55 <span type="species:ncbi:9606">human</span>
Selection of reference genes for real-time PCR in human hepatocellular carcinoma tissues
###end article-title 129
###begin article-title 130
###xml 107 112 <span type="species:ncbi:9606">human</span>
Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma
###end article-title 130
###begin article-title 131
###xml 60 65 <span type="species:ncbi:9606">human</span>
Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases
###end article-title 131
###begin article-title 132
###xml 53 70 <span type="species:ncbi:10407">hepatitis B virus</span>
###xml 122 130 <span type="species:ncbi:9606">patients</span>
###xml 146 163 <span type="species:ncbi:10407">hepatitis B virus</span>
The expression of hypoxia-inducible factor-1alpha in hepatitis B virus-related hepatocellular carcinoma: correlation with patients' prognosis and hepatitis B virus X protein
###end article-title 132
###begin article-title 133
X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization
###end article-title 133
###begin article-title 134
The potential role of hypoxia inducible factor 1alpha in tumor progression after hypoxia and chemotherapy in hepatocellular carcinoma
###end article-title 134
###begin article-title 135
Antisense hypoxia-inducible factor 1alpha gene therapy enhances the therapeutic efficacy of doxorubicin to combat hepatocellular carcinoma
###end article-title 135
###begin article-title 136
Hypoxia and hypoxia inducible factors (HIF) as important regulators of tumor physiology
###end article-title 136
###begin article-title 137
###xml 79 84 <span type="species:ncbi:9606">human</span>
Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells
###end article-title 137
###begin article-title 138
Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock
###end article-title 138
###begin article-title 139
Hypoxia level and matrix metalloproteinases-2 and -9 activity in Lewis lung carcinoma: correlation with metastasis
###end article-title 139
###begin article-title 140
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis
###end article-title 140
###begin article-title 141
HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1alpha
###end article-title 141
###begin article-title 142
Hypoxia regulates PDGF-B interactions between glomerular capillary endothelial and mesangial cells
###end article-title 142
###begin article-title 143
Hypoxia induces an autocrine-paracrine survival pathway via platelet-derived growth factor (PDGF)-B/PDGF-beta receptor/phosphatidylinositol 3-kinase/Akt signaling in RN46A neuronal cells
###end article-title 143
###begin article-title 144
Cyclooxygenase-2 in hepatocellular carcinoma
###end article-title 144
###begin article-title 145
Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue
###end article-title 145
###begin article-title 146
###xml 76 81 <span type="species:ncbi:9606">human</span>
Repression of alpha-fetoprotein gene expression under hypoxic conditions in human hepatoma cells: characterization of a negative hypoxia response element that mediates opposite effects of hypoxia inducible factor-1 and c-Myc
###end article-title 146

